Clinical Trial Update: Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali [Phase 2]

View source ↗

Summary

Phase II malaria vaccine trial (AMA-1 FMP2.1/AS02A) conducted in Mali has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• FMP2.1/AS02A

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED | Results posted: 2010-08-10